BAX and metabolic dysfunction-associated steatohepatitis: Eguchi et al. optimized the BID siRNA delivery system, enabling efficient accumulation in the liver, which effectively reduces BID levels and is accompanied by a decrease in mitochondrial BAX and BAK, thereby improving NASH-related liver fibrosis and alleviating the inflammatory response [112].